Table 2 |
|||
|
Comparison of comorbidities of the patients in studies by Rivers and colleagues [2] and Sprung and colleagues (CORTICUS) [23] |
|||
|
Rivers et al. |
Sprung et al. |
||
|
(n = 263) |
(n = 499) |
Chi-square test |
|
|
|
|||
|
Caucasian (%) |
Not reported |
93 |
|
|
Age (years) |
65.7 |
63 |
|
|
Male/Female (%) |
50.6/49.4 |
66.5/33.5 |
0.0000 |
|
Hypertension (%) |
67.3 |
37.7a |
0.0000 |
|
Coronary artery disease (%) |
25.0 |
16.9a |
0.0080 |
|
Congestive heart failure (%) |
33.4 |
6.0a |
0.0000 |
|
Diabetes (%) |
31.4 |
21.6a |
0.0030 |
|
Chronic obstructive pulmonary disease (%) |
15.7 |
11.3a |
0.0900 |
|
Chronic renal failure (%) |
21.7 |
8.7a |
0.0000 |
|
Liver disease (%) |
23.3 |
8.1a |
0.0000 |
|
Neurologic disease (%) |
33.0 |
11.7a |
0.0000 |
|
Cancer (%) |
11.4 |
16.9a |
0.0580 |
|
Alcohol use (%) |
38.6 |
Not reported |
|
|
|
|||
|
an = 496. CORTICUS, Corticosteroid Therapy of Septic Shock. |
|||
|
Perel Critical Care 2008 12:223 doi:10.1186/cc6979 |
|||